Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 113 publications
Early onset gastrointestinal cancers - a needs analysis.
Journal: Frontiers in oncology
Published: April 30, 2026
Real-world insights into young-onset gastroesophageal adenocarcinoma: an all-Ireland population-based cancer registry analysis.
Journal: ESMO gastrointestinal oncology
Published: April 23, 2026
Size-exclusion chromatography as a clinically applicable method for extracellular vesicles collection as liquid biopsies shows potential diagnostic relevance and correlation with poorer outcome in common cancer types.
Journal: Translational oncology
Published: February 26, 2026
Quantitative benefit-risk assessment of data from the phase III ClarIDHy study of ivosidenib versus placebo in patients with mIDH1 cholangiocarcinoma.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Relative Clinical Efficacy and Safety of Second- or Later-Line Treatments for Advanced and Metastatic Gastric Cancer: A Rapid Review and Network Meta-Analysis.
Journal: Journal of gastrointestinal cancer
Published: July 14, 2025
First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 18, 2025
International Fibrolamellar Cancer Registry: Opportunities and Challenges.
Journal: JCO global oncology
Published: June 11, 2025
Overview of Molecular Diagnostics in Irish Clinical Oncology.
Journal: HRB open research
Published: June 05, 2025
Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170].
Journal: The Lancet regional health. Europe
Published: May 19, 2025
Pembrolizumab with trastuzumab and chemotherapy for HER2-positive advanced gastric cancer: health-related quality-of-life analysis from the randomized KEYNOTE-811 trial.
Journal: ESMO open
Published: April 08, 2025
Mechanisms of Resistance to PARPi in Pancreatic Ductal Adenocarcinoma.
Journal: Journal of cellular and molecular medicine
Published: January 29, 2025
Pembrolizumab in HER2-Positive Gastric Cancer.
Journal: The New England journal of medicine
Published: September 16, 2024
Last Updated: 09/26/2026